Mitochondrial mutation in fatal infantile cardiomyopathyMasashi Tanaka, Shinji Itoyama, Kinji Ohno et al.|The Lancet|1990Cited by 168
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Yasuhiro Takikawa, Takayoshi Oikawa et al.|Liver Cancer|2022Cited by 45
Associations of environmental exposures to methylmercury and selenium with female infertility: A case–control studyEri Maeda, Yukihiro Terada, Katsuyuki Murata et al.|Environmental Research|2018Cited by 41
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, JapanMasashi Fujita, Hiromasa Ohira, Kazumichi Abe et al.|Scientific Reports|2022Cited by 17
Mitochondrial DNA Disease: Phylogeny and ExpressionTakayuki Ozawa, Makoto Yoneda, Masashi Tanaka et al.|Elsevier eBooks|1991Cited by 0